Literature DB >> 29885812

A clinical study of HMME-PDT therapy in Chinese pediatric patients with port-wine stain.

Gan Li-Qiang1, Wang Hua2, Ni Si-Li2, Tan Chun-Hua2.   

Abstract

OBJECTIVE: To report our observations from a trial of the effectiveness and safety of hematoporphyrin monomethyl ether photodynamic therapy (HMME-PDT) in treating Chinese Pediatric patients port-wine stains (PWS).
METHOD: From October 2017 to December 2017, the study recruited 82 patients of PWS with negative HMME skin test results. The patients received an intravenous injection of 5 mg/kg HMME and the affected areas were exposed to 532 nm LED green light, with the irradiation power density between 80-85 mW/cm2. Each light spot was irradiated for 20-25 min. After two treatments, the clinical efficacy and posttreatment reactions at each treated area were observed. RESULT: The patient age between 1 and 14 years old. 24 of the 82 cases were cured (29.27%) after two HMME-PDT treatment, 34 cases indicates a good efficacy (41.46%), 16 cases showed alleviation (19.51%), while 8 cases displayed no efficacy (9.76%). Pain was observed during treatment, and post-treatment edema was observed at the treated areas. No other obvious systematic adverse reaction were reported.
CONCLUSION: HMME-PDT is an effective and safe treatment for pediatric patients with PWS.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chinese pediatric patients; Hematoporphyrin monomethyl ether; Photodynamic therapy; Port-wine stain

Mesh:

Substances:

Year:  2018        PMID: 29885812     DOI: 10.1016/j.pdpdt.2018.06.006

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  8 in total

Review 1.  A promising anticancer drug: a photosensitizer based on the porphyrin skeleton.

Authors:  Qizhi Zhang; Jun He; Wenmei Yu; Yanchun Li; Zhenhua Liu; Binning Zhou; Yunmei Liu
Journal:  RSC Med Chem       Date:  2020-02-25

2.  Clinical outcome measures and scoring systems used in prospective studies of port wine stains: A systematic review.

Authors:  M Ingmar van Raath; Sandeep Chohan; Albert Wolkerstorfer; Chantal M A M van der Horst; Jacqueline Limpens; Xuan Huang; Baoyue Ding; Gert Storm; René R W J van der Hulst; Michal Heger
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

Review 3.  Site-specific pharmaco-laser therapy: A novel treatment modality for refractory port wine stains.

Authors:  M Ingmar van Raath; Jojanneke E van Amesfoort; Martin Hermann; Yasin Ince; Maurice J Zwart; Agustina V Echague; Yan Chen; Baoyue Ding; Xuan Huang; Gert Storm; Michal Heger
Journal:  J Clin Transl Res       Date:  2019-05-01

Review 4.  Effect of Different Wavelengths of Laser Irradiation on the Skin Cells.

Authors:  Aleksandra Cios; Martyna Cieplak; Łukasz Szymański; Aneta Lewicka; Szczepan Cierniak; Wanda Stankiewicz; Mariola Mendrycka; Sławomir Lewicki
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

5.  Hemoporfin-Mediated Photodynamic Therapy for Port-Wine Stains: Multivariate Analysis of Clinical Efficacy and Optical Coherence Tomography Appearance.

Authors:  Yanyan Lin; Wei Gong; Jie Kang; Yuhong Fang; Jingjing Liu; Lihang Lin; Xuemin Xiao
Journal:  Front Med (Lausanne)       Date:  2022-02-24

6.  The Efficacy of Hematoporphyrin Monomethyl Ether Photodynamic Therapy in Adult Patients with Port-Wine Stains: A Retrospective Study.

Authors:  Xin-Yu Zhang; Najwa Al-Odaini; Run-Ge Fan; Hong-di Xiong; Jia-Can Huang; Hong-Mei Dai; Yan-Hua Zhou; Xiu-Yin Huang; Si-Jian Wen
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-04

7.  Photodynamic Therapy Using HMME for Port-Wine Stains: Clinical Effectiveness and Sonographic Appearance.

Authors:  Ahmad Taha Khalaf; Yonghong Sun; Fang Wang; Minmin Sheng; Yan Li; Xiaoming Liu
Journal:  Biomed Res Int       Date:  2020-07-30       Impact factor: 3.411

Review 8.  Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber Syndrome.

Authors:  Sara Sabeti; Karen L Ball; Craig Burkhart; Lawrence Eichenfield; Esteban Fernandez Faith; Ilona J Frieden; Roy Geronemus; Deepti Gupta; Andrew C Krakowski; Moise L Levy; Denise Metry; J Stuart Nelson; Megha M Tollefson; Kristen M Kelly
Journal:  JAMA Dermatol       Date:  2021-01-01       Impact factor: 10.282

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.